Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Peer Review channel feed
Exclusive: GV’s first network development partner completes ‘full circle’; Just when Enzyvant scores an approval, Rachelle Jacques plans her exit
4 years ago
Tillman Gerngross leads a pack of biotech CEOs out the door; With eyes on pipeline expansion, Poseida woos a gene therapy exec from Novartis
4 years ago
Amgen, Ipsen vet moves up the ladder with Coherus' anti-PD-1 awaiting PDUFA; It takes a village to replace Frank Clyburn at Merck's Human Health business
4 years ago
With sotrovimab in the balance, Biogen vet reunites with George Scangos at Vir; First woman to chair PhRMA has more in store at Takeda
4 years ago
Lyell CSO: New job is 'the missing piece' of his career; Orphazyme and Cortexyme and Sio, oh my: Your guide to the latest CEO changes
4 years ago
Blueprint Medicines gets more ducks in a row before CEO transition; Paul Stoffels has his work cut out for him at Gilead’s crumbling partner
4 years ago
As Hal Barron steals the show, there’s no off position on the John Maraganore switch; Danny Bar-Zohar makes another leap forward at Merck KGaA
4 years ago
Eric Ostertag reaching the end of the line as Poseida chief, will become executive chairman; Alector exec named CEO of Pfizer-backed LNP biotech
4 years ago
How family and science moved Exelixis' new CMO to work on oncology blockbusters; While John Maraganore racks up the prizes, his old crew at Alnylam selects president
4 years ago
Joan Shen ends the year by saying goodbye to I-Mab; CRISPR Therapeutics puts coal in R&D chief's stocking
4 years ago
Sara Kenkare-Mitra leaves Genentech for a chance to lead neuro R&D; GlaxoSmithKline alum jumps to Vifor Pharma with the lid lifted on sale to CSL
4 years ago
Flagship on center stage: Axcella’s new CMO likens the biotech to ‘professional sports team’; Life after the FDA takes shape for Stephen Hahn as a chief executive
4 years ago
Joseph Arron marches to the beat of his own drum at 23andMe; Ex-Voyager CFO joins Sek Kathiresan at Verve Therapeutics
4 years ago
Taking a leave of absence, Ampio Pharmaceuticals CEO passes baton to a new board member; Axel Hoos' cancer biotech lands a CFO
4 years ago
Takeda oncology vet drills down the 'basics' at cell therapy startup; Sarepta promotes new R&D chief
4 years ago
CytoImmune CEO breaks down her 3 'pillars' of success; Former Novartis, Gilead exec Alessandro Riva to lead an ultra low-profile cell therapy outfit
4 years ago
Pierre Beaurang hits the ground running at his 3rd startup; Mike Grey poaches Astellas dealmaker to head protein degradation player
4 years ago
Alnylam’s John Maraganore isn’t the only CEO to leave his post; CRISPR’s chief commercial officer takes the helm at a protein degradation player
4 years ago
Bridget Martell on taking Yale spinout 'to adulthood'; Cullinan Oncology CEO announces resignation as Bristol Myers hematology exec is welcomed aboard
4 years ago
Luba Greenwood takes the helm at Kojin Therapeutics, steering an all-female C-suite; Alexion R&D chief packs up for change of scenery at VC firm
4 years ago
Flagship turns to Novartis HR guru in latest addition; David Grainger saddles up to new position at Centessa while Pfizer's Rod MacKenzie prepares to ride into the sunset
4 years ago
Sporos Bioventures taps first CEO during period of 'explosive growth'; In the wake of murky Hunter syndrome data, Denali bulks up C-suite
4 years ago
With Maverick now in Takeda's hands, James Scibetta turns the page; Roivant CMO leaves in favor of small IL-2 biotech
4 years ago
A Pfizer partner welcomes ex-ADC Therapeutics CMO Jay Feingold to the team; Amid tough sledding, Immunovant chooses Eli Lilly alum as CFO
4 years ago
First page
Previous page
5
6
7
8
9
10
11
Next page
Last page